Lipid peroxidation in mouse models of atherosclerosis

被引:25
作者
Praticò, D
机构
[1] Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S1050-1738(01)00099-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the past decade, oxidative modification of low-density lipoprotein (LDL) has been implicated in atherogenesis. This hypothesis has been supported indirectly by a number of in vitro and ex-vivo observations demonstrating the pro-atherogenic properties of oxidized LDL, their occurrence in atherosclerotic lesions and some positive results in animal studies with antioxidants. Only recently, however, have small mammalian models (mouse) of atherosclerosis been created by gene manipulation and widely used by investigators to better elucidate this pathogenetic aspect of such a complex disease. Transgenic animal models combined with the availability of more reliable, specific and sensitive markers of in vivo lipid peroxidation have now provided consistent evidence for a direct and functional role of oxidant stress In atherogenesis. The identification of yet unknown initiating event(s) of in vivo oxidant stress will be the challenge for the future. This should finally provide the basis for the development of most effective antioxidant agents that could modulate atherogenesis. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
[31]   F2-isoprostanes:: sensitive and specific non-invasive indices of lipid peroxidation in vivo [J].
Praticò, D .
ATHEROSCLEROSIS, 1999, 147 (01) :1-10
[32]   Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2α-VI levels and the extent of atherosclerosis in ApoE-deficient mice:: modulation by vitamin E [J].
Praticò, D ;
Tangirala, RK ;
Hörkkö, S ;
Witztum, JL ;
Palinski, W ;
FitzGerald, GA .
BLOOD, 2001, 97 (02) :459-464
[33]   Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice [J].
Praticò, D ;
Tangirala, RK ;
Rader, DJ ;
Rokach, J ;
FitzGerald, GA .
NATURE MEDICINE, 1998, 4 (10) :1189-1192
[34]  
PRATICO D, 2001, IN PRESS LIPIDS
[35]   OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS - A POTENTIAL ROLE IN RECRUITMENT AND RETENTION OF MONOCYTE MACROPHAGES DURING ATHEROGENESIS [J].
QUINN, MT ;
PARTHASARATHY, S ;
FONG, LG ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (09) :2995-2998
[36]   INDUCTION OF ENDOTHELIAL-CELL EXPRESSION OF GRANULOCYTE AND MACROPHAGE COLONY-STIMULATING FACTORS BY MODIFIED LOW-DENSITY LIPOPROTEINS [J].
RAJAVASHISTH, TB ;
ANDALIBI, A ;
TERRITO, MC ;
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
LUSIS, AJ .
NATURE, 1990, 344 (6263) :254-257
[37]   EFFECT OF PROBUCOL DOSAGE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS AND ON PROTECTION OF LOW-DENSITY-LIPOPROTEIN AGAINST INVITRO OXIDATION IN HUMANS [J].
REAVEN, PD ;
PARTHASARATHY, S ;
BELTZ, WF ;
WITZTUM, JL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (03) :318-324
[38]   Dietary β-carotene and α-tocopherol combination does not inhibit atherogenesis in an apoE-deficient mouse model [J].
Shaish, A ;
George, J ;
Gilburd, B ;
Keren, P ;
Levkovitz, H ;
Harats, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1470-1475
[39]   Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis [J].
Shih, DM ;
Xia, YR ;
Wang, XP ;
Miller, E ;
Castellani, LW ;
Subbanagounder, G ;
Cheroutre, H ;
Faull, KF ;
Berliner, JA ;
Witztum, JL ;
Lusis, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17527-17535
[40]   LOW-DENSITY-LIPOPROTEIN IS PROTECTED FROM OXIDATION AND THE PROGRESSION OF ATHEROSCLEROSIS IS SLOWED IN CHOLESTEROL-FED RABBITS BY THE ANTIOXIDANT N,N'-DIPHENYL-PHENYLENEDIAMINE [J].
SPARROW, CP ;
DOEBBER, TW ;
OLSZEWSKI, J ;
WU, MS ;
VENTRE, J ;
STEVENS, KA ;
CHAO, YS .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :1885-1891